School of Chemical Engineering and Technology, Tianjin University, Yaguan Road 135, Tianjin 300350, China; Collaborative Innovation Center of Chemical Science and Chemical Engineering (Tianjin), Weijin Road 92, Tianjin 300072, China.
Department of Hepatopancreatobiliary and Splenic Medicine, Affiliated Hospital, Logistics University of People's Armed Police Force, Chenglin Road 220, Tianjin 300162, China.
Acta Biomater. 2019 Oct 1;97:344-359. doi: 10.1016/j.actbio.2019.07.057. Epub 2019 Aug 1.
Surface modification by conjugating biomolecules has been widely proved to enhance biocompatibility of small-caliber artificial vascular grafts. In this study, we aimed at developing a multifunctional vascular graft that provides not only good hemocompatibility but also in situ rapid endothelialization. Herein, a vascular graft (inner diameter ∼2 mm) was fabricated by electrospinning with poly(lactic acid-co-caprolactone) and gelatin, and then biofunctionalized with antithrombotic peptide with sequence LTFPRIVFVLG (ACH) and cell adhesion peptide with sequence CAG through adhesive poly(dopamine) coating. We developed this graft with the synergistic properties of low thrombogenicity and rapid endothelialization. The successful grafting of both CAG and ACH peptides was confirmed by Fourier transform infrared spectroscopy and X-ray photoelectron spectroscopy. The surface micromorphology of the modified surfaces was observed by field emission scanning electron microscopy. Our results demonstrated that the multifunctional surface suppressed the denaturation of absorbed fibrinogen, hindered coagulation factor Xa activation, and inhibited platelet adhesion and aggregation. Importantly, this modified surface could selectively enhance endothelial cells adhesion, proliferation and release of nitric oxide. Upon in vivo implantation of 6 weeks, the multifunctional vascular graft showed improved patency and superior vascular endothelialization. Overall, the results effectively demonstrated that the co-immobilization of ACH and CAG provided a promising method for the improvement of hemocompatibility and endothelialization of vascular grafts. STATEMENT OF SIGNIFICANCE: Electrospun small-caliber vascular grafts are increasingly used to treat cardiovascular diseases. Despite their success related to their good biodegradation and mechanical strength, they have some drawbacks, such as low hemocompatibility and endothelialization. The single-function ligands are insufficient to modify surface with both good hemocompatibility and rapid endothelialization simultaneously. Therefore, we functionalized electrospun vascular graft by novel antithrombotic peptide and cell-adhesive peptide to construct superior anticoagulation and ECs-selective adhesion surface in present study. The multifunctional vascular grafts benefit for high long-term patency and rapid endothelialization.
通过将生物分子偶联进行表面修饰已被广泛证实可以提高小口径人工血管移植物的生物相容性。在本研究中,我们旨在开发一种多功能血管移植物,它不仅提供良好的血液相容性,而且还具有原位快速内皮化的功能。在此,我们通过静电纺丝技术制备了一种血管移植物(内径约为 2mm),其材料由聚(丙交酯-共-己内酯)和明胶组成,然后通过粘性聚多巴胺涂层将具有抗血栓肽序列 LTFPRIVFVLG(ACH)和细胞黏附肽序列 CAG 的生物功能化。我们开发了这种具有低血栓形成性和快速内皮化协同特性的移植物。傅里叶变换红外光谱和 X 射线光电子能谱证实了 CAG 和 ACH 肽的成功接枝。通过场发射扫描电子显微镜观察修饰表面的表面微观形态。我们的研究结果表明,多功能表面抑制了吸附纤维蛋白原的变性,阻止了凝血因子 Xa 的激活,并抑制了血小板的黏附和聚集。重要的是,这种修饰表面可以选择性地增强内皮细胞的黏附、增殖和一氧化氮的释放。在体内植入 6 周后,多功能血管移植物表现出更好的通畅性和更好的血管内皮化。总的来说,这些结果有效地证明了 ACH 和 CAG 的共同固定为改善血管移植物的血液相容性和内皮化提供了一种有前途的方法。